Vanguard Group Inc

13F Holdings History for Intellia Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NTLA)

Symbol: NTLA on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Ownership: 10.2M shares
Security Ownership: 10%

Shares, Excluding Options vs Price

Value, Excluding Options

The Vanguard Group ownership in Intellia Therapeutics, Inc. Common Stock, par value $0.0001 per share (NTLA)

2025-01-08 - The Vanguard Group has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 10.2M shares of Intellia Therapeutics, Inc. Common Stock, par value $0.0001 per share (NTLA). This represents 10% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
The Vanguard Group	10%		$75.5M	10.2M			$7.41	13G/A	12/31/2024	8 Jan 2025 11:29:29

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	0%	+0%	$191M	11M	+192,651	+1.78%	$17.27	Q3 2025
6/30/2025	0%	+0%	$102M	10.9M	+100,138	+0.93%	$9.38	Q2 2025
3/31/2025	0%	+0%	$76.4M	10.8M	+561,978		$7.11	Q1 2025
12/31/2024	0%	+0%	$119M	10.2M	+562,249	+5.84%	$11.66	Q4 2024
9/30/2024	0%	+0%	$198M	9.63M	+527,736	+5.8%	$20.55	Q3 2024
6/30/2024	0%	+0%	$204M	9.1M	+6,356	+0.07%	$22.38	Q2 2024
3/31/2024	0%	+0%	$250M	9.09M	+746,263	+8.94%	$27.51	Q1 2024
12/31/2023	0.01%	+0%	$255M	8.35M	+155,579	+1.9%	$30.49	Q4 2023
9/30/2023	0.01%	+0%	$259M	8.19M	+6,719	+0.08%	$31.62	Q3 2023
6/30/2023	0.01%	+0%	$334M	8.19M	+52,373	+0.64%	$40.78	Q2 2023
3/31/2023	0.01%	+0%	$303M	8.13M	+322,552	+4.13%	$37.27	Q1 2023
12/31/2022	0.01%	+0%	$272M	7.81M	+1,192,903	+18%	$34.89	Q4 2022
9/30/2022	0.01%	+0%	$370M	6.62M	+108,041	+1.66%	$55.96	Q3 2022
6/30/2022	0.01%	+0%	$337M	6.51M	+117,342	+1.84%	$51.76	Q2 2022
3/31/2022	0.01%	0%	$465M	6.39M	-50,415	-0.78%	$72.67	Q1 2022
12/31/2021	0.02%	+0%	$762M	6.44M	+89,021	+1.4%	$118.24	Q4 2021
9/30/2021	0.02%	+0%	$852M	6.35M	+327,157	+5.43%	$134.15	Q3 2021
6/30/2021	0.02%	+0%	$976M	6.03M	+447,433	+8.02%	$161.91	Q2 2021
3/31/2021	0.01%	+0%	$448M	5.58M	+447,547	+8.72%	$80.26	Q1 2021
12/31/2020	0.01%	+0%	$279M	5.13M	+754,398	+17.2%	$54.40	Q4 2020
9/30/2020	0%	+0%	$87M	4.38M	+119,603	+2.81%	$19.88	Q3 2020
6/30/2020	0%	+0%	$89.5M	4.26M	+768,947	+22%	$21.02	Q2 2020
3/31/2020	0%	0%	$42.7M	3.49M	-35,950	-1.02%	$12.23	Q1 2020
12/31/2019	0%	+0%	$51.7M	3.52M	+71,738	+2.08%	$14.67	Q4 2019
9/30/2019	0%	+0%	$46.1M	3.45M	+268,345	+8.43%	$13.35	Q3 2019
6/30/2019	0%	+0%	$52.1M	3.18M	+371,724	+13.2%	$16.37	Q2 2019
3/31/2019	0%	+0%	$48M	2.81M	+66,266	+2.41%	$17.08	Q1 2019
12/31/2018	0%	+0%	$37.5M	2.75M	+92,961	+3.5%	$13.65	Q4 2018
9/30/2018	0%	+0%	$75.9M	2.65M	+287,682	+12.2%	$28.62	Q3 2018
6/30/2018	0%	+0%	$64.7M	2.37M	+355,970	+17.7%	$27.36	Q2 2018
3/31/2018	0%	+0%	$42.4M	2.01M	+173,032	+9.42%	$21.09	Q1 2018
12/31/2017	0%	+0%	$35.3M	1.84M	+791,188	+75.7%	$19.22	Q4 2017
9/30/2017	0%	+0%	$26M	1.05M	+48,005	+4.81%	$24.85	Q3 2017
6/30/2017	0%	+0%	$16M	997K	+92,580	+10.2%	$16.00	Q2 2017
3/31/2017	0%	+0%	$12.7M	905K	+33,925	+3.9%	$14.09	Q1 2017
12/31/2016	0%	+0%	$11.4M	871K	+431,153	+98.1%	$13.11	Q4 2016
9/30/2016	0%	+0%	$7.48M	440K	+23,066	+5.54%	$17.02	Q3 2016
6/30/2016	0%	+0%	$8.89M	417K	+416,564	NEW	$21.35	Q2 2016

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.